1                                          Out of 8600 abstracts, 19 international studies comparing ad

2                                              Of 501 abstracts, 217 (43%) were later published as comp

3                                              Of 3458 abstracts, 224 full papers were reviewed and 122

4                                              Of 3851 abstracts, 25 observational studies (23 prospect

5                           Approximately half of the abstracts (53%; 255/478; 95% CI, 49%-57%) identif

6 ntially relevant citations, and after review of the abstracts, 63 were selected for full-text review.

7                                              Of 10424 abstracts, 707 full-text articles were reviewed

8 ence were included after duplicate screening of titles, abstracts, and full articles, including only

9 Eligible articles were selected after review of titles, abstracts, and references.

10                            Sequential review of titles, abstracts, and text from retrieved articles.

11 rpus was constructed to present four classes of pharmacokinetics abstracts: in vivo pharmacokinetics

12 t publish their manuscript than were authors of rejected abstracts (OR, 0.23; 95% CI, 0.0001-0.61).

13 ted PPCP abstracts, appearing in 51% and 39% of reviewed abstracts, respectively, in comparison to ho

14        The method processes a large database of article abstracts, synthesizing information from many

15  extracting PPI triplets from a large number of PubMed abstracts, that our method was able to complem

16 , PREMEDLINE, HEALTHSTAR, Cambridge Register of Conference Abstracts, the Dissertation and Thesis Dat

17                                              Of 1357 abstracts, we included 11 trials with data for 6

18                                  In the case of Medline abstracts, Whatizit offers access to EBI's in

19 d protein names can be applied to large sets of MEDLINE abstracts, without the need for special condi